Diagnosis and treatment of arterial hypertension [Guidelines]

Diagnosis and treatment of arterial hypertension [Guidelines]

Bibliographic Details
Main Authors:	I E Chazova, Yu V Zhernakova
Format:	Article
Language:	Russian
Published:	IP Morozov P.V. 2019-03-01
Series:	Системные гипертензии
Subjects:	антигипертензивная терапия артериальное давление целевые значения артериального давления измерение артериального давления сердечно-сосудистые осложнения сердечно-сосудистый риск динамическое наблюдение рекомендации гипертония образ жизни поражение органов-мишеней
Online Access:	https://syst-hypertension.ru/2075-082X/article/viewFile/33520/pdf

Similar Items

2013 ESH/ESC GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION
by: Giuseppe Mancia, et al.
Published: (2014-01-01)

Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii
by: G Mancia, et al.
Published: (2013-09-01)

MODERN VIEWS ON THE VARIABILITY OF BLOOD PRESSURE
by: V. M. Gorbunov
Published: (2015-12-01)

Ot idei k klinicheskoy praktike: pervye rezul'taty Rossiyskogo natsional'nogo issledovaniya optimal'nogo snizheniya arterial'nogo davleniya (ROSA)
by: I E Chazova, et al.
Published: (2004-06-01)

COMPARATIVE EVALUATION OF ENALAPRIL AND DILTIAZEM EFFICACY IN MENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2015-12-01)

CONTEMPORARY PROBLEMS OF EVALUATION OF HYPERTENSION TREATMENT EFFICACY: MASKED HYPERTENSION AND WHITE COAT HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2016-01-01)

INFLUENCE OF CHRONOTHERAPY WITH DIFFERENT ANTIHYPERTENSIVE DRUGS ON CIRCADIAN BLOOD PRESSURE PATTERN
by: V. M. Gorbunov, et al.
Published: (2016-01-01)

MULTI-CHANNEL VOLUME SPHYGMOGRAPHY IN CARDIOANGIOLOGICAL SCREENING OF THE ADULT POPULATION
by: R. A. Khokhlov, et al.
Published: (2015-09-01)

ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE
by: M. V. Surovtseva, et al.
Published: (2015-12-01)

ДИСЛИПИДЕМИИ: ОБЗОР РЕКОМЕНДАЦИЙ ESC/EAS 2019 ПО ДИАГНОСТИКЕ И ЛЕЧЕНИЮ. ЧАСТЬ 2 – ТАРГЕТНАЯ ТЕРАПИЯ
by: V. M. Pyrochkin, et al.
Published: (2021-05-01)

CORRELATION OF STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE WITH AMBULATORY BLOOD PRESSURE MONITORING DATA IN PATIENTS WITH ESSENTIAL HYPERTENSION
by: O. M. Khromtsova, et al.
Published: (2016-01-01)

Korotkiy put' k zavetnoy tseli – ko-renitek dlya patsienta s AG
by: I E Chazova, et al.
Published: (2005-06-01)

Otsenka effektivnosti moeksiprila u bol'nykh myagkoy i umerennoy arterial'noy gipertoniey s gipertrofiey miokarda levogo zheludochka (issledovanie ENIGMA)
by: Yu N Belenkov, et al.
Published: (2005-03-01)

EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Achievement of target blood pressure in patients with arterial hypertension on the background of antihypertensive therapy in real clinical practice
by: S. V. Nedogoda, et al.
Published: (2018-12-01)

THE RATE AND CHARACTERS OF MASKED ARTERIAL HYPERTENSION AND MASKED INEFFECTIVENESS OF HYPERTENSION TREATMENT IN INDUSTRIAL WORKERS ACCORDING TO THE PREVENTIVE EXAMINATION
by: M. I. Smirnova, et al.
Published: (2015-09-01)

ASSESSMENT OF AMLODIPINE ANTIHYPERTENSIVE EFFECT HOMOGENEITY IN CONTROLLED TRIAL
by: V. M. Gorbunov, et al.
Published: (2016-01-01)

EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS
by: A. L. Hohlov, et al.
Published: (2015-12-01)

ВЛИЯНИЕ ОБРАЗОВАТЕЛЬНОГО СТАТУСА МУЖЧИН И ЖЕНЩИН НА РИСК ФАТАЛЬНЫХ СЕРДЕЧНО-СОСУДИСТЫХ ОСЛОЖНЕНИЙ
by: E. A. Sharlaeva, et al.
Published: (2015-11-01)

Rossiyskoe mnogotsentrovoe issledovanie FAGOT (farmakoekonomicheskaya otsenka ispol'zovaniya ingibitorov angiotenzinprevrashchayushchego fermenta v ambulatornom lechenii bol'nykh arterial'noy gipertoniey oslozhnennogo techeniya)
by: I E Chazova
Published: (2004-03-01)

REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS
by: M. N. Mamedov, et al.
Published: (2015-12-01)

NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY
by: A. V. Rudenko, et al.
Published: (2015-09-01)

ПУТИ ПОВЫШЕНИЯ ЭФФЕКТИВНОСТИ ПЕРВИЧНОЙ ПРОФИЛАКТИКИ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ ДЛЯ СОХРАНЕНИЯ ТРУДОСПОСОБНОСТИ НАСЕЛЕНИЯ
by: Vladimir Anatolievich Reshetnikov, et al.
Published: (2016-05-01)

FEATURES OF INDICATORS OF DAILY MONITORING OF ARTERIAL PRESSURE IN MEN WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE CONTEXT OF COMORBIDITY
by: Evgeny Vyacheslavovich Kozlov, et al.
Published: (2019-05-01)

EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES
by: O. V. Fedorishina, et al.
Published: (2016-01-01)

TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY
by: V. E. Oleinikov, et al.
Published: (2015-12-01)

АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ И ГИПОТИРЕОЗ В ФАЗЕ МЕДИКАМЕНТОЗНОЙ СУБКОМПЕНСАЦИИ
Published: (2006-12-01)

СИНДРОМ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ И ДИФФЕРЕНЦИАЛЬНЫЙ ДИАГНОЗ: ЗНАЧЕНИЕ КЛИНИЧЕСКОГО И СУТОЧНОГО АРТЕРИАЛЬНОГО ДАВЛЕНИЯ
Published: (2005-12-01)

Total glucose control: the role of post-prandial glucose
by: PAUL S JELLINGER
Published: (2004-06-01)

Anatomically optimized distal renal denervation — sustained blood pressure lowering efficacy during 3 years after the intervention
by: S. E. Pekarskiy, et al.
Published: (2020-11-01)

Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii
by: G Mancia, et al.
Published: (2013-12-01)

Circadian blood pressure profile in patients with arterial hypertension and chronic obstructive pulmonary disease
by: T. E. Steshina, et al.
Published: (2005-08-01)

Duration of abpm as an important prerequisite for a reliable diagnosis of vascular variability disorders (VVDs)
by: L Z Gumarova, et al.
Published: (2013-12-01)

Personalized chronome (time structure) complements genome detecting vascular variability disorders (vvds), including mesor-hypertension
by: G Cornélissen, et al.
Published: (2010-12-01)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01)

Rasprostranennost' ozhireniya,kardiometabolicheskikh faktorov riska,metabolicheskogo sindroma i sakharnogo diabetasredi zhenshchin razlichnykh vozrastnykh gruppMoskovskogo regiona
Published: (2009-12-01)

АЛГОРИТМ СТРАТИФИКАЦИИ СЕРДЕЧНО-СОСУДИСТОГО РИСКА У МУЖЧИН В ВОЗРАСТЕ 18-29 ЛЕТ С СИНДРОМОМ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ
by: A. N. Zayats, et al.
Published: (2021-05-01)

Kombinirovannaya terapiya arterial'noy gipertenzii s pozitsiy profilaktiki serdechno-sosudistykh oslozhneniy i patogeneza
by: S A Boytsov
Published: (2004-06-01)

Klinicheskoe znachenie disfunktsii endoteliya pri arterial'noy gipertonii
by: D V Nebieridze
Published: (2005-03-01)